Viridian Therapeutics, Inc.\DE (VRDN) FCF Margin Growth (5y) (2018 - 2026)
Viridian Therapeutics, Inc.\DE (VRDN) FCF Margin Growth (5y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Viridian Therapeutics, Inc.\DE | 229.55 Mn | 229.55 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.41 Mn |
| Dec 31, 2025 | -70,320.00 |
| Jun 30, 2025 | -9.65 Mn |
| Mar 31, 2025 | -12.78 Mn |
| Sep 30, 2024 | -7.83 Mn |
| Jun 30, 2024 | -6.39 Mn |
| Mar 31, 2024 | -5.96 Mn |
| Dec 31, 2023 | -5.11 Mn |
| Sep 30, 2023 | -5.40 Mn |
| Jun 30, 2023 | -6.30 Mn |
| Mar 31, 2023 | -6.32 Mn |
| Dec 31, 2022 | -3.16 Mn |
| Sep 30, 2022 | -142,583.00 |
| Jun 30, 2022 | -599,450.00 |
| Mar 31, 2022 | -804,380.00 |
| Dec 31, 2021 | -696,207.00 |
| Sep 30, 2021 | -549,311.00 |
| Jun 30, 2021 | -93,840.00 |
| Mar 31, 2021 | -32,905.00 |
| Dec 31, 2020 | -1.73 Mn |